Lisata extends tender offer deadline to April 13, 2026 per waiver

LISATA THERAPEUTICS, INC.

Deadline to commence tender offer moved from April 3 to April 13, 2026.
Waiver signed April 2 by Lisata, Kuva Labs Inc., and Kuva Acquisition Corp.
All other Merger Agreement terms (March 6, 2026) remain unchanged.

item 8.01 item 9.01

LISATA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-26-013070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.